SpineThera SALIENT

CONDITION

Other

GENDER

Both males and females

AGE GROUP

From 18

to 65 years

STATUS

Recruiting

A double-Blind, Randomised, Placebo-Controlled, Parallel Group Phase 1/11, First-in-Human Study to Assess the Safety and Efficacy of Two Doses of SX600 Administered by Lumbosacral Transforaminal Epidural Injection in Patients with Radicular Pain Secondary to Lumbar Intervertebral Disc Hernaiation

SpineThera

CONTACT DETAILS

Clinical Trial Site: CerCare Pty Ltd
Phone Number: 08 8340 7733 Email: sally.schultz@painmedsa.com Location: 5 Greenhill Road, Wayville SA 5034, Australia
  • Hidden

Approved By: Bellberry HREC              

Clinical Trial Registry Link: